CN104844839A - Preparation method of magnetic fluorescent composite nanoparticle - Google Patents
Preparation method of magnetic fluorescent composite nanoparticle Download PDFInfo
- Publication number
- CN104844839A CN104844839A CN201510124944.4A CN201510124944A CN104844839A CN 104844839 A CN104844839 A CN 104844839A CN 201510124944 A CN201510124944 A CN 201510124944A CN 104844839 A CN104844839 A CN 104844839A
- Authority
- CN
- China
- Prior art keywords
- magnetic
- preparation
- chitosan
- acid
- quantum dot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 70
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 43
- 239000002131 composite material Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 229920001661 Chitosan Polymers 0.000 claims abstract description 52
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 41
- 239000002096 quantum dot Substances 0.000 claims abstract description 40
- 239000002122 magnetic nanoparticle Substances 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 239000002245 particle Substances 0.000 claims abstract description 19
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 14
- 238000004132 cross linking Methods 0.000 claims abstract description 13
- 150000002500 ions Chemical class 0.000 claims abstract description 12
- 230000009471 action Effects 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 239000012153 distilled water Substances 0.000 claims description 32
- 229910004613 CdTe Inorganic materials 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- 239000002114 nanocomposite Substances 0.000 claims description 21
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical group [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 claims description 20
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 claims description 18
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 10
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 10
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000001913 cellulose Substances 0.000 claims description 8
- 239000006249 magnetic particle Substances 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- -1 amino, carboxyl Chemical group 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 5
- 229910052759 nickel Inorganic materials 0.000 claims description 5
- 239000004065 semiconductor Substances 0.000 claims description 5
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 5
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 238000000975 co-precipitation Methods 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 4
- 150000004706 metal oxides Chemical class 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- CFPHMAVQAJGVPV-UHFFFAOYSA-N 2-sulfanylbutanoic acid Chemical compound CCC(S)C(O)=O CFPHMAVQAJGVPV-UHFFFAOYSA-N 0.000 claims description 2
- JSGPBRQYMLFVJQ-UHFFFAOYSA-N 2-sulfanylhexanoic acid Chemical compound CCCCC(S)C(O)=O JSGPBRQYMLFVJQ-UHFFFAOYSA-N 0.000 claims description 2
- IMGGANUNCHXAQF-UHFFFAOYSA-N 2-sulfanylpentanoic acid Chemical compound CCCC(S)C(O)=O IMGGANUNCHXAQF-UHFFFAOYSA-N 0.000 claims description 2
- 229910045601 alloy Inorganic materials 0.000 claims description 2
- 239000000956 alloy Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 2
- 230000005294 ferromagnetic effect Effects 0.000 claims description 2
- 229940005740 hexametaphosphate Drugs 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 229960003151 mercaptamine Drugs 0.000 claims description 2
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910001172 neodymium magnet Inorganic materials 0.000 claims description 2
- 230000005298 paramagnetic effect Effects 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 229910000938 samarium–cobalt magnet Inorganic materials 0.000 claims description 2
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 229920002521 macromolecule Polymers 0.000 claims 5
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 claims 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 229920006184 cellulose methylcellulose Polymers 0.000 claims 2
- GFLJTEHFZZNCTR-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OCCCOC(=O)C=C GFLJTEHFZZNCTR-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- QJVKUMXDEUEQLH-UHFFFAOYSA-N [B].[Fe].[Nd] Chemical compound [B].[Fe].[Nd] QJVKUMXDEUEQLH-UHFFFAOYSA-N 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000003534 oscillatory effect Effects 0.000 claims 1
- 239000001205 polyphosphate Substances 0.000 claims 1
- 235000011176 polyphosphates Nutrition 0.000 claims 1
- ACTRVOBWPAIOHC-UHFFFAOYSA-N succimer Chemical compound OC(=O)C(S)C(S)C(O)=O ACTRVOBWPAIOHC-UHFFFAOYSA-N 0.000 claims 1
- 239000002086 nanomaterial Substances 0.000 abstract description 5
- 238000003384 imaging method Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000029918 bioluminescence Effects 0.000 abstract description 2
- 238000005415 bioluminescence Methods 0.000 abstract description 2
- 229920000447 polyanionic polymer Polymers 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 2
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 abstract 1
- 238000011017 operating method Methods 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 60
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000007853 buffer solution Substances 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000005416 organic matter Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 108010024636 Glutathione Proteins 0.000 description 4
- 230000001588 bifunctional effect Effects 0.000 description 4
- 150000007942 carboxylates Chemical class 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229910000859 α-Fe Inorganic materials 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 229920000867 polyelectrolyte Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 2
- 238000007885 magnetic separation Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 239000011684 sodium molybdate Substances 0.000 description 2
- 235000015393 sodium molybdate Nutrition 0.000 description 2
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AEUVIXACNOXTBX-UHFFFAOYSA-N 1-sulfanylpropan-1-ol Chemical compound CCC(O)S AEUVIXACNOXTBX-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- NJRXVEJTAYWCQJ-UHFFFAOYSA-N thiomalic acid Chemical compound OC(=O)CC(S)C(O)=O NJRXVEJTAYWCQJ-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种多功能纳米复合微球的制备方法,具体涉及一种磁性荧光复合纳米颗粒的制备方法,该复合微粒同时具备了量子点的荧光性能和磁性纳米颗粒的磁性能,可用作生物体内靶向定位和生物荧光成像方面。 The invention relates to a method for preparing multifunctional nanocomposite microspheres, in particular to a method for preparing magnetic fluorescent composite nanoparticles. The composite particles have both the fluorescent properties of quantum dots and the magnetic properties of magnetic nanoparticles, and can be used as In vivo targeting and bioluminescence imaging.
背景技术 Background technique
量子点和磁学纳米微粒已经在很多领域尤其是生物医学领域显示出明显的优势。但他们往往只具有单一的功能,如量子点的荧光标记、磁性微粒的磁性分离等,如果将两种功能-分离和标记功能溶于一体,通过一定的物理化学工艺制备出新型的磁性荧光纳米复合材料,使其作为荧光探针的同时,还具有良好的磁响应特性。因此,磁性荧光纳米颗粒具有磁分离与荧光示踪双重功能,其性能和应用范围都远远超过了单一功能的纳米粒子,不仅可以进行生物分子水平上的检测和分离;还实现了多种模式成像,即荧光成像、磁共振成像(MRI)和激光共聚焦显微成像。 Quantum dots and magnetic nanoparticles have shown obvious advantages in many fields, especially in the field of biomedicine. However, they often only have a single function, such as fluorescent labeling of quantum dots, magnetic separation of magnetic particles, etc. If the two functions-separation and labeling functions are integrated, a new type of magnetic fluorescent nanometer can be prepared through a certain physical and chemical process. The composite material makes it a fluorescent probe and also has good magnetic response characteristics. Therefore, magnetic fluorescent nanoparticles have dual functions of magnetic separation and fluorescent tracking, and their performance and application range far exceed those of single-function nanoparticles. They can not only detect and separate biomolecules, but also realize multiple modes. Imaging, namely fluorescence imaging, magnetic resonance imaging (MRI) and confocal laser microscopy imaging.
到目前为止,磁性荧光复合材料的常用制备方法包括层层自组装法、包埋法、以及共价结合法等。包埋法(encapsulation)是目前较为简单成熟的一种实现磁性纳米粒子与量子点组装的方法。主要过程是,预先制备磁性纳米粒子和量子点,然后将利用表面活性剂、聚电解质分子等将其一起包埋于内核中,从而形成磁性荧光复合的纳米/微米球。利用聚合物在包覆两种纳米粒子的同时还能保留聚合物的特性。其外壳材料要求有良好的生物相容性和结构稳定性,同时还要易于进一步表面功能化修饰,以便与特定的目标分子进行连接,最终实现靶向性。 So far, the common preparation methods of magnetic fluorescent composite materials include layer-by-layer self-assembly method, embedding method, and covalent bonding method. Encapsulation is a relatively simple and mature method to realize the assembly of magnetic nanoparticles and quantum dots. The main process is to pre-prepare magnetic nanoparticles and quantum dots, and then use surfactants, polyelectrolyte molecules, etc. to embed them together in the inner core to form magnetic fluorescent composite nano/microspheres. The use of polymers can retain the properties of the polymers while coating the two nanoparticles. Its shell material requires good biocompatibility and structural stability, and at the same time, it is easy to further surface functional modification, so as to connect with specific target molecules and finally achieve targeting.
以可生物降解的高分子材料作为包覆材料,具有无毒、可生物降解、良好的组织相容性等特点,在医学及生物领域有着广泛的应用前景。羧甲基壳聚糖作为壳聚糖的一种衍生物,是壳聚糖经羧甲基化得到的带负电荷的水溶性多糖,它具有无毒、无刺激、无致敏性、无致突变作用、无溶血效应,良好的生物相容性、生物降解性和黏附性,同时克服了壳聚糖只能溶于酸性溶液的缺陷,显示出了普通壳聚糖不具有的优良性质。 Using biodegradable polymer materials as coating materials has the characteristics of non-toxicity, biodegradability, and good tissue compatibility, and has broad application prospects in the fields of medicine and biology. As a derivative of chitosan, carboxymethyl chitosan is a negatively charged water-soluble polysaccharide obtained by carboxymethylation of chitosan. It is non-toxic, non-irritating, non-allergenic, and non-toxic Mutagenesis, no hemolytic effect, good biocompatibility, biodegradability and adhesion, and at the same time overcome the defect that chitosan can only be dissolved in acidic solution, showing the excellent properties that ordinary chitosan does not have.
离子交联法是指在离子交联剂作用下,原料中的大分子链间通过化学键联结起来,形成网状或体形结构高分子材料的方法。离子交联法通常也叫物理交联法,其优点是制备过程中不使用有机溶剂,避免了大部分化学交联剂如戊二醛交联剂对人体的危害,所以这种方法被广泛使用。 The ionic cross-linking method refers to the method in which the macromolecular chains in the raw materials are linked by chemical bonds under the action of an ionic cross-linking agent to form a network or body-shaped polymer material. The ionic cross-linking method is usually also called the physical cross-linking method. Its advantage is that no organic solvent is used in the preparation process, and it avoids the harm of most chemical cross-linking agents such as glutaraldehyde cross-linking agents to the human body, so this method is widely used .
发明内容 Contents of the invention
本发明的目的在于提供一种离子交联法制备磁性荧光复合纳米颗粒的方法,该方法制备的复合纳米微粒具有磁响应性强、光稳定性高、制备工艺简单、分散性好且尺寸均匀等优点,同时由于高分子有机物的包覆作用,制备出的复合纳米颗粒还具有高的比表面积、良好生物相容性、生物功能性及生物可降解性等特点,在纳米生物技术领域具有更广泛的应用。 The purpose of the present invention is to provide a method for preparing magnetic fluorescent composite nanoparticles by ion cross-linking. The composite nanoparticles prepared by the method have strong magnetic responsiveness, high photostability, simple preparation process, good dispersion and uniform size, etc. At the same time, due to the coating effect of polymer organic matter, the prepared composite nanoparticles also have the characteristics of high specific surface area, good biocompatibility, biofunctionality and biodegradability, and have a wider range of applications in the field of nanobiotechnology. Applications.
本发明是通过以下措施实现的: The present invention is achieved through the following measures:
一种磁性荧光复合纳米颗粒的制备方法,采用以下步骤: A method for preparing magnetic fluorescent composite nanoparticles, using the following steps:
(a)采用共混包埋法制备羧甲基壳聚糖磁性纳米复合物(CMCH-MNPs): (a) Preparation of carboxymethyl chitosan magnetic nanocomposites (CMCH-MNPs) by blending embedding method:
①称取50-500mg磁性纳米颗粒溶于30 mL pH =7.4,浓度为0.01mol/L的PBS缓冲溶液中,通氮气去氧,利用超声波清洗机将磁性粒子分散均匀;②称取10-800 mg羧甲基壳聚糖溶于20 mL pH =7.4的PBS缓冲溶液中,同时加入0.1-0.5 g 1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDAC)活化羧甲基壳聚糖表面的基团;③将①和②两溶液混合,在恒温水浴振荡器中25℃振荡2-6 h,再依次用蒸馏水和PBS( pH=7.4)缓冲溶液充分洗涤,即得到羧甲基壳聚糖磁性纳米复合物; ① Weigh 50-500 mg of magnetic nanoparticles and dissolve them in 30 mL of PBS buffer solution with a pH = 7.4 and a concentration of 0.01mol/L, pass nitrogen gas to remove oxygen, and use an ultrasonic cleaner to disperse the magnetic particles evenly; ② Weigh 10-800 mg carboxymethyl chitosan was dissolved in 20 mL pH = 7.4 PBS buffer solution, while adding 0.1-0.5 g 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDAC ) to activate the groups on the surface of carboxymethyl chitosan; ③ Mix the two solutions ① and ②, shake in a constant temperature water bath shaker at 25°C for 2-6 h, and then use distilled water and PBS (pH=7.4) buffer solution to fully Washing to obtain the carboxymethyl chitosan magnetic nanocomposite;
(b)采用离子交联法制备磁性荧光复合纳米颗粒: (b) Preparation of magnetic fluorescent composite nanoparticles by ion cross-linking method:
取制备的浓缩的水相量子点溶于蒸馏水中,并加入聚阴离子型高分子有机物和离子交联剂,其中聚阴离子型高分子有机物和离子交联剂的质量浓度分别为0.33-6.67 mg/mL和0.67-2.67 mg/mL,得到反应溶液A;取0.005-0.05g步骤(a)中制备的羧甲基壳聚糖修饰的磁性纳米复合物溶于蒸馏水中,超声20-60 min,使磁性纳米微粒分散均匀,并加入聚二烯丙基二甲基氯化铵得到反应溶液B;将反应溶液A逐滴加入到反应溶液B中,常温下振荡反应2-10 h,离心分离,蒸馏水洗涤,即得到磁性荧光复合纳米颗粒;其中聚二烯丙基二甲基氯化铵:聚阴离子型高分子有机物:离子交联剂的质量比为1:0.1-2:0.01-0.5。 Take the prepared concentrated aqueous phase quantum dots and dissolve them in distilled water, and add polyanionic macromolecular organic matter and ionic cross-linking agent, wherein the mass concentrations of polyanionic macromolecular organic matter and ionic cross-linking agent are 0.33-6.67 mg/ mL and 0.67-2.67 mg/mL to obtain reaction solution A; take 0.005-0.05 g of the carboxymethyl chitosan-modified magnetic nanocomposite prepared in step (a) and dissolve it in distilled water, sonicate for 20-60 min to make The magnetic nanoparticles are uniformly dispersed, and polydiallyldimethylammonium chloride is added to obtain the reaction solution B; the reaction solution A is added dropwise to the reaction solution B, and the reaction is shaken at room temperature for 2-10 h, centrifuged, distilled water After washing, the magnetic fluorescent composite nanoparticles are obtained; wherein the mass ratio of polydiallyldimethylammonium chloride: polyanionic macromolecular organic matter: ion crosslinking agent is 1:0.1-2:0.01-0.5.
本发明所述的磁性荧光复合纳米颗粒的制备,磁性荧光复合纳米颗粒的粒径为10-220 nm;磁性纳米颗粒(MNPs)是具有超顺磁、顺磁或铁磁性的金属及金属氧化物,选自Fe3O4、Fe2O3、MeFe2O4(Me=Co、Mn、Ni)、化合物钕铁硼、钐钴等、金属Fe、Co、Ni以及合金Fe2Co、Ni2Fe的金属氧化物的纳米颗粒中的一种;磁性纳米颗粒的制备方法包括共沉淀法、水热法;磁性纳米颗粒表面含有羟基、氨基、羧基中的至少一种。 The preparation of magnetic fluorescent composite nanoparticles in the present invention, the particle size of magnetic fluorescent composite nanoparticles is 10-220 nm; magnetic nanoparticles (MNPs) are metals and metal oxides with superparamagnetic, paramagnetic or ferromagnetic , selected from Fe 3 O 4 , Fe 2 O 3 , MeFe 2 O 4 (Me=Co, Mn, Ni), compounds NdFeB, SmCo, etc., metals Fe, Co, Ni and alloys Fe 2 Co, Ni 2 One of the nanoparticles of metal oxides of Fe; the preparation method of the magnetic nanoparticles includes a co-precipitation method and a hydrothermal method; the surface of the magnetic nanoparticles contains at least one of hydroxyl, amino and carboxyl groups.
本发明所述的量子点为表面带有亲水基团的水溶性量子点,量子点为II-VI族半导体材料,或者为II-VI族半导体材料形成的复合材料,所述量子点粒径为1.5-10 nm;优选的量子点为ZnSe、CdSe、CdTe、CdS、ZnSe/ZnS、CdS/ZnS、CdSe/ZnS、CdTe/ZnS、ZnXCd1-XSe、CdSe1-XSX、CdSe1-XTeX、CdSe/ZnSe、CdS/ZnSe、CdTe/ZnSe、CdSe/CdS、CdTe/CdS、CdS/ZnXCd1-XS、ZnSe/ZnXCd1-XS、CdSe/ZnXCd1-XS或CdTe/ZnXCd1-XS中的一种,其中0<X<1。 The quantum dots of the present invention are water-soluble quantum dots with hydrophilic groups on the surface, and the quantum dots are II-VI group semiconductor materials, or composite materials formed by II-VI group semiconductor materials, and the particle size of the quantum dots is 1.5-10 nm; preferred quantum dots are ZnSe, CdSe, CdTe, CdS, ZnSe/ZnS, CdS/ZnS, CdSe/ZnS, CdTe/ZnS, Zn X Cd 1-X Se, CdSe 1-X S X , CdSe 1-X Te X , CdSe/ZnSe, CdS/ZnSe, CdTe/ZnSe, CdSe/CdS, CdTe/CdS, CdS/Zn X Cd 1-X S, ZnSe/Zn X Cd 1-X S, CdSe/Zn One of X Cd 1-X S or CdTe/Zn X Cd 1-X S, where 0<X<1.
本发明所述的离子交联剂包括三聚磷酸盐、四聚磷酸盐、六偏磷酸盐、焦磷酸盐、钼酸盐、透明质酸或γ-聚谷氨酸中的一种或几种;聚阴离子型高分子有机物羧甲基纤维素钠、纤维素硫酸钠、纤维素羧酸钠、羧酸纤维素、羧甲基壳聚糖、羧甲基纤维素钾或羧甲基纤维素钠钾中的一种或几种;所述的羧甲基壳聚糖可选用O-羧甲基壳聚糖或N, O-羧甲基壳聚糖;聚二烯丙基二甲基氯化铵的分子量和质量浓度分别为1×105~2×105和0.51~5.1 mg/mL。 The ionic cross-linking agent of the present invention includes one or more of tripolyphosphate, tetrapolyphosphate, hexametaphosphate, pyrophosphate, molybdate, hyaluronic acid or γ-polyglutamic acid ;Polyanionic macromolecular organic matter sodium carboxymethyl cellulose, sodium cellulose sulfate, sodium cellulose carboxylate, cellulose carboxylate, carboxymethyl chitosan, potassium carboxymethyl cellulose or sodium carboxymethyl cellulose One or more of potassium; the carboxymethyl chitosan can be selected from O-carboxymethyl chitosan or N, O-carboxymethyl chitosan; polydiallyl dimethyl chloride The molecular weight and mass concentration of ammonium are 1×10 5 ~2×10 5 and 0.51~5.1 mg/mL, respectively.
本发明所述的磁性荧光复合纳米颗粒制备,步骤(a)中羧甲基壳聚糖在磁性纳米颗粒表面的厚度为3-10 nm;步骤(b)中羧甲基壳聚糖磁性纳米复合物与量子点的摩尔比为1:1~1:20。 The preparation of magnetic fluorescent composite nanoparticles of the present invention, the thickness of carboxymethyl chitosan on the surface of magnetic nanoparticles in step (a) is 3-10 nm; the magnetic nanocomposite of carboxymethyl chitosan in step (b) The molar ratio of matter to quantum dots is 1:1~1:20.
本发明所述量子点表面含有巯基、羧基、氨基中的至少一种;半导体量子点合成中所使用的亲水基团配体包括3-巯基丙酸、巯基乙酸、L-半胱氨酸、2-巯基丙酸、巯基丁酸、巯基戊酸、巯基己酸、巯基丁二酸、巯基乙醇、谷胱甘肽、巯基丙醇或巯基乙胺中的一种或几种。 The quantum dot surface of the present invention contains at least one of mercapto, carboxyl, and amino groups; the hydrophilic group ligands used in the synthesis of semiconductor quantum dots include 3-mercaptopropionic acid, thioglycolic acid, L-cysteine, One or more of 2-mercaptopropionic acid, mercaptobutyric acid, mercaptovaleric acid, mercaptocaproic acid, mercaptosuccinic acid, mercaptoethanol, glutathione, mercaptopropanol or mercaptoethylamine.
本发明的有益效果: Beneficial effects of the present invention :
(1)本发明中选用水溶性羧甲基壳聚糖及其它多糖衍生物代替普通的壳聚糖,避免酸性介质的使用,排除了酸性介质带来的不良影响,扩大了在生物医学领域的应用范围; (1) In the present invention, water-soluble carboxymethyl chitosan and other polysaccharide derivatives are selected to replace common chitosan, avoiding the use of acidic medium, eliminating the adverse effects caused by acidic medium, and expanding the scope of application in the field of biomedicine. scope of application;
(2)本发明通过离子交联法利用相反电荷聚电解质物质之间的静电作用组装成磁性荧光复合纳米颗粒,无需使用有机溶剂,反应条件温和,可最大限度保护生物分子的活性; (2) The present invention uses the electrostatic interaction between oppositely charged polyelectrolyte substances to assemble magnetic fluorescent composite nanoparticles through ionic cross-linking, without using organic solvents, and the reaction conditions are mild, which can protect the activity of biomolecules to the greatest extent;
(3)本发明选择聚二烯丙基二甲基氯化铵(PDDA)作为阳离子聚电解质,它具有安全、无毒、易溶于水且水解稳定性好、凝聚力强等特性,避免了使用其它有机聚合物电解质造成的生物毒性; (3) The present invention selects polydiallyldimethylammonium chloride (PDDA) as the cationic polyelectrolyte, which is safe, non-toxic, easily soluble in water, has good hydrolytic stability and strong cohesion, and avoids the use of Biological toxicity caused by other organic polymer electrolytes;
(4)本发明中由于羧甲基壳聚糖对磁性微粒的修饰作用,有效避免了磁性材料的泄漏及对量子点的荧光淬灭作用;最终产物的粒径大小、荧光性能及磁性能,可以通过调控水溶性量子点与磁性纳米颗粒的摩尔比、聚阴离子型高分子有机物的浓度、离子交联剂浓度等,制得不同性能的磁性荧光复合纳米颗粒,可以用来进行生物体定向药物运输和生物体荧光成像;同时,本发明制备工艺简单、条件温和,对活性物质能起到最大程度的保护。 (4) Due to the modification of magnetic particles by carboxymethyl chitosan in the present invention, the leakage of magnetic materials and the fluorescence quenching effect on quantum dots are effectively avoided; the particle size, fluorescent properties and magnetic properties of the final product, Magnetic fluorescent composite nanoparticles with different properties can be prepared by adjusting the molar ratio of water-soluble quantum dots to magnetic nanoparticles, the concentration of polyanionic polymer organic matter, and the concentration of ion cross-linking agents, which can be used for biologically oriented drugs. Transportation and biological fluorescence imaging; at the same time, the preparation process of the invention is simple, the conditions are mild, and the active substances can be protected to the greatest extent.
附图说明 Description of drawings
图1 磁性荧光复合纳米颗粒的XRD图谱 Fig.1 XRD patterns of magnetic fluorescent composite nanoparticles
图2 磁性荧光复合纳米颗粒的荧光光谱和吸收光谱 Fig.2 Fluorescence and absorption spectra of magnetic fluorescent composite nanoparticles
图3磁性荧光复合纳米颗粒的TEM照片 Fig.3 TEM photo of magnetic fluorescent composite nanoparticles
图4磁性荧光复合纳米颗粒的磁滞回线。 Fig. 4 Hysteresis loops of magnetic fluorescent composite nanoparticles.
具体实施方式 Detailed ways
下面通过具体实施例说明本发明的技术方案,但是本发明的技术方案不以具体实施例为限。 The technical solution of the present invention is described below through specific examples, but the technical solution of the present invention is not limited to the specific examples.
实施例1: Example 1:
1.1 水相制备CdTe量子点。在氮气保护下,将0.0945g NaBH4与0.0063g Te粉溶于5 mL蒸馏水中,加热至40℃,完全溶解后得到NaHTe溶液;取0.293 g Cd(Ac)2溶入100 mL蒸馏水中,待其完全溶解后加入2.0 mmol巯基乙酸,用1mol/L的NaOH溶液调节pH=11,得到Cd的前驱体溶液;将Cd的前驱体转入三口瓶中,在氮气保护下迅速注入NaHTe溶液,油浴100℃回流,磁力搅拌3h后取出放入冰箱中快速冷却至室温,得到红色溶液,即为制备好的CdTe QDs溶液。 1.1 Preparation of CdTe quantum dots in aqueous phase. Under nitrogen protection, dissolve 0.0945g NaBH 4 and 0.0063g Te powder in 5 mL distilled water, heat to 40°C, and obtain NaHTe solution after completely dissolving; take 0.293 g Cd(Ac) 2 and dissolve it in 100 mL distilled water, wait After it was completely dissolved, 2.0 mmol thioglycolic acid was added, and the pH was adjusted to 11 with 1 mol/L NaOH solution to obtain a Cd precursor solution; the Cd precursor was transferred into a three-necked flask, and NaHTe solution was quickly injected under nitrogen protection, and the oil The bath was refluxed at 100°C, magnetically stirred for 3 hours, then taken out and placed in a refrigerator to cool rapidly to room temperature to obtain a red solution, which was the prepared CdTe QDs solution.
1.2 采用水热法制备Fe3O4纳米颗粒。称取3 g FeCl3溶于80 mL乙二醇中搅拌超声溶解,加入分子量为2000的聚乙二醇2 g,醋酸钠7 g,搅拌超声使之溶解,将前驱体溶液转入水热反应釜中,在200℃反应5 h,反应完成后将所得溶液用水与无水乙醇交替洗涤,经真空干燥,得到干燥的Fe3O4磁性纳米颗粒。 1.2 Preparation of Fe 3 O 4 nanoparticles by hydrothermal method. Weigh 3 g of FeCl 3 and dissolve it in 80 mL of ethylene glycol, stir and ultrasonically dissolve, add 2 g of polyethylene glycol with a molecular weight of 2000, and 7 g of sodium acetate, stir and ultrasonically dissolve it, and transfer the precursor solution to hydrothermal reaction In the kettle, react at 200°C for 5 h. After the reaction is completed, the obtained solution is alternately washed with water and absolute ethanol, and dried in vacuum to obtain dry Fe 3 O 4 magnetic nanoparticles.
1.3采用共混包埋法制备羧甲基壳聚糖磁性纳米复合物(Fe3O4-CMCH)。称取0.08 g Fe3O4磁性纳米颗粒溶于30 mL pH =7.4,浓度为0.01mol/L的PBS缓冲溶液中,通氮气去氧,利用超声波清洗机将磁性粒子分散均匀,得到分散均匀的Fe3O4纳米颗粒溶液;称取0.2 g羧甲基壳聚糖溶于20 mL pH =7.4的PBS缓冲溶液中,同时加入0.1 g 1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDAC)活化羧甲基壳聚糖表面的基团;之后将羧甲基壳聚糖溶液加入Fe3O4纳米颗粒溶液,在恒温水浴振荡器中25℃振荡2 h,反应结束后用磁铁收集产物,再依次用蒸馏水和PBS( pH=7.4)缓冲溶液充分洗涤,即得到羧甲基壳聚糖磁性纳米复合物。 1.3 The carboxymethyl chitosan magnetic nanocomposite (Fe 3 O 4 -CMCH) was prepared by blending embedding method. Weigh 0.08 g of Fe 3 O 4 magnetic nanoparticles and dissolve them in 30 mL of PBS buffer solution with a pH of 7.4 and a concentration of 0.01mol/L, pass nitrogen gas to remove oxygen, and use an ultrasonic cleaner to disperse the magnetic particles evenly to obtain a uniformly dispersed Fe 3 O 4 nanoparticle solution; Weigh 0.2 g carboxymethyl chitosan and dissolve it in 20 mL pH = 7.4 PBS buffer solution, add 0.1 g 1-ethyl-(3-dimethylaminopropyl) at the same time Carbodiimide hydrochloride (EDAC) activates the groups on the surface of carboxymethyl chitosan; then the carboxymethyl chitosan solution is added to the Fe 3 O 4 nanoparticle solution, and shaken in a constant temperature water bath shaker at 25°C for 2 h, after the reaction, the product was collected with a magnet, and then washed thoroughly with distilled water and PBS (pH=7.4) buffer solution in turn to obtain the carboxymethyl chitosan magnetic nanocomposite.
1.4采用离子交联法制备磁性荧光复合纳米颗粒。取1.1制备的浓缩的水相CdTe量子点,异丙醇分离提纯后溶于5mL蒸馏水中,并加入多聚磷酸钠和羧甲基壳聚糖,其中多聚磷酸钠和羧甲基壳聚糖的浓度分别为1 mg/mL和1.5 mg/mL,CdTe量子点浓度为0.04mol/L,得到反应溶液A;取0.01g步骤1.3中制备的羧甲基壳聚糖修饰的磁性纳米复合物溶于10 mL蒸馏水中,超声30 min,使磁性纳米微粒分散均匀,并加入质量浓度为1 mg/mL 聚二烯丙基二甲基氯化铵,得到反应溶液B;将A溶液逐滴加入B溶液中,在25℃的恒温水浴振荡器中振荡4h,磁铁收集反应产物,用蒸馏水清洗反应产物,即得磁性荧光双功能纳米材料。图1磁性荧光复合纳米颗粒的XRD图谱。 1.4 Prepare magnetic fluorescent composite nanoparticles by ionic cross-linking method. Take the concentrated water-phase CdTe quantum dots prepared in 1.1, separate and purify them with isopropanol, dissolve them in 5 mL of distilled water, and add sodium polyphosphate and carboxymethyl chitosan, wherein sodium polyphosphate and carboxymethyl chitosan The concentration of CdTe quantum dots was 1 mg/mL and 1.5 mg/mL respectively, and the concentration of CdTe quantum dots was 0.04mol/L to obtain reaction solution A; take 0.01g of carboxymethyl chitosan modified magnetic nanocomposite solution prepared in step 1.3 In 10 mL of distilled water, sonicate for 30 min to disperse the magnetic nanoparticles evenly, and add polydiallyldimethylammonium chloride with a mass concentration of 1 mg/mL to obtain a reaction solution B; add solution A to B dropwise The solution was shaken in a constant temperature water bath oscillator at 25° C. for 4 hours, the reaction product was collected by a magnet, and the reaction product was washed with distilled water to obtain a magnetic fluorescent bifunctional nanomaterial. Fig. 1 XRD patterns of magnetic fluorescent composite nanoparticles.
实施例2: Example 2:
2.1采用水相法制备CdTe/ZnS量子点. 首先采用化学共沉淀法制备CdTe量子点,制备方法如上述实施例1中所述,不同点是反应时间为4h。取制备好的CdTe量子点溶在30 mL蒸馏水中,其中CdTe量子点的浓度为1.67×10-3 mol/L,加入0.0329 g Zn(Ac)2、0.0921 g还原性谷胱甘肽,用配置好的浓度为1 mol/L NaOH溶液调节pH值为8,在磁力搅拌下,油浴100℃回流,磁力搅拌反应2 h后放入冰箱快速冷却至室温,得到水溶性高发光效率的CdTe/ZnS量子点。 2.1 Preparation of CdTe/ZnS quantum dots by the aqueous phase method. First, the chemical co-precipitation method was used to prepare CdTe quantum dots. The preparation method was as described in Example 1 above, except that the reaction time was 4h. Take the prepared CdTe quantum dots and dissolve them in 30 mL distilled water, in which the concentration of CdTe quantum dots is 1.67×10 -3 mol/L, add 0.0329 g Zn(Ac) 2 , 0.0921 g reduced glutathione, and use the configuration The best concentration is 1 mol/L NaOH solution to adjust the pH value to 8. Under magnetic stirring, the oil bath is refluxed at 100 ° C. After the magnetic stirring reaction for 2 hours, put it in the refrigerator and quickly cool it to room temperature to obtain water-soluble CdTe/ ZnS quantum dots.
2.2采用水热法制备Fe3O4磁性纳米颗粒。取2.78 g FeSO4·7H2O、4.32 g FeCl3·6H2O溶于30 mL蒸馏水中,磁力搅拌溶解后,再加入30 mL乙二醇,搅拌均匀后在氮气保护下,加入三口瓶中,用配置好的浓度为2 mol/L的NaOH溶液调节pH至9-11,加入表面活性剂聚乙烯吡咯烷酮0.15 g,充分搅拌后反应30min,制得Fe3O4磁性纳米颗粒的前驱体。将Fe3O4磁性纳米颗粒的前驱体转入水热反应釜中,在160℃下反应6h。反应完成后将所得溶液用水与无水乙醇交替洗涤,经真空干燥,得到干燥的Fe3O4磁性纳米颗粒。 2.2 Preparation of Fe 3 O 4 magnetic nanoparticles by hydrothermal method. Dissolve 2.78 g FeSO 4 7H 2 O and 4.32 g FeCl 3 6H 2 O in 30 mL of distilled water, stir to dissolve, then add 30 mL of ethylene glycol, stir evenly, and put it into a three-necked flask under nitrogen protection , adjust the pH to 9-11 with the prepared NaOH solution with a concentration of 2 mol/L, add 0.15 g of surfactant polyvinylpyrrolidone, stir well and react for 30 min to prepare the precursor of Fe 3 O 4 magnetic nanoparticles. The precursor of Fe 3 O 4 magnetic nanoparticles was transferred into a hydrothermal reactor and reacted at 160°C for 6h. After the reaction was completed, the obtained solution was alternately washed with water and absolute ethanol, and dried in vacuum to obtain dry Fe 3 O 4 magnetic nanoparticles.
2.3采用共混包埋法制备羧甲基壳聚糖磁性纳米复合物(Fe3O4-CMCH)。称取0.2 g Fe3O4磁性纳米颗粒溶于30 mL pH =7.4,浓度为0.01mol/L的PBS缓冲溶液中,通氮气去氧,利用超声波清洗机将磁性粒子分散均匀,得到分散均匀的Fe3O4纳米颗粒溶液;称取0.5 g羧甲基壳聚糖溶于20 mL pH =7.4的PBS缓冲溶液中,同时加入0.3 g 1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDAC)活化羧甲基壳聚糖表面的基团;之后将羧甲基壳聚糖溶液加入Fe3O4纳米颗粒溶液,在恒温水浴振荡器中25℃振荡4 h,反应结束后用磁铁收集产物,再依次用蒸馏水和PBS( pH=7.4)缓冲溶液充分洗涤,即得到羧甲基壳聚糖磁性纳米复合物。 2.3 The carboxymethyl chitosan magnetic nanocomposite (Fe 3 O 4 -CMCH) was prepared by blending embedding method. Weigh 0.2 g of Fe 3 O 4 magnetic nanoparticles and dissolve them in 30 mL of PBS buffer solution with a pH of 7.4 and a concentration of 0.01 mol/L, pass nitrogen gas to remove oxygen, and use an ultrasonic cleaner to disperse the magnetic particles evenly to obtain a uniformly dispersed Fe 3 O 4 nanoparticle solution; Weigh 0.5 g carboxymethyl chitosan and dissolve it in 20 mL PBS buffer solution with pH = 7.4, add 0.3 g 1-ethyl-(3-dimethylaminopropyl) at the same time Carbodiimide hydrochloride (EDAC) activated the groups on the surface of carboxymethyl chitosan; then the carboxymethyl chitosan solution was added to the Fe 3 O 4 nanoparticle solution and shaken in a constant temperature water bath shaker at 25°C for 4 h, after the reaction, the product was collected with a magnet, and then washed thoroughly with distilled water and PBS (pH=7.4) buffer solution in turn to obtain the carboxymethyl chitosan magnetic nanocomposite.
2.4 采用离子交联法制备磁性荧光复合纳米颗粒。取2.1制备的浓缩的水相CdTe/ZnS量子点,异丙醇分离提纯后溶于5mL蒸馏水中,并加入四聚磷酸钠和羧甲基纤维素钠,其中四聚磷酸钠和羧甲基纤维素钠的浓度分别为1.5 mg/mL和3 mg/mL,CdTe/ZnS量子点浓度为0.05mol/L,得到反应溶液A;取0.02 g步骤2.3中制备的羧甲基壳聚糖修饰的磁性纳米复合物溶于10 mL蒸馏水中,超声30 min,使磁性纳米颗粒分散均匀,并加入质量浓度为2 mg/mL 聚二烯丙基二甲基氯化铵,得到反应溶液B;将A溶液逐滴加入B溶液中,在25℃的恒温水浴振荡器中振荡6h,磁铁收集反应产物,用蒸馏水清洗反应产物,即得磁性荧光双功能纳米材料。图2为制备的磁性荧光复合纳米颗粒的荧光光谱和吸收光谱。 2.4 Preparation of magnetic fluorescent composite nanoparticles by ion cross-linking method. Take the concentrated water-phase CdTe/ZnS quantum dots prepared in 2.1, separate and purify them with isopropanol, dissolve them in 5 mL of distilled water, and add sodium tetrapolyphosphate and sodium carboxymethylcellulose, wherein sodium tetrapolyphosphate and carboxymethylcellulose The concentration of plain sodium was 1.5 mg/mL and 3 mg/mL respectively, and the concentration of CdTe/ZnS quantum dots was 0.05mol/L to obtain reaction solution A; take 0.02 g of carboxymethyl chitosan-modified magnetic The nanocomposite was dissolved in 10 mL distilled water, ultrasonicated for 30 min to disperse the magnetic nanoparticles evenly, and polydiallyldimethylammonium chloride was added with a mass concentration of 2 mg/mL to obtain reaction solution B; Add dropwise to solution B, shake in a constant temperature water bath shaker at 25°C for 6 hours, collect the reaction product with a magnet, wash the reaction product with distilled water, and obtain the magnetic fluorescent bifunctional nanomaterial. Fig. 2 is the fluorescence spectrum and absorption spectrum of the prepared magnetic fluorescent composite nanoparticles.
实施例3: Example 3:
3.1 ZnSe/ZnS量子点溶液的制备。首先采用化学共沉淀法制备ZnSe量子点,在氮气保护下,将0.01g NaBH4与0.0061g Se粉溶于2 mL蒸馏水中,加热至40℃,完全溶解后得到NaHSe溶液;取0.0439 g Zn(Ac)2溶入20 mL蒸馏水中,待其完全溶解后加入还原型谷胱甘肽0.0737g,用1mol/L的NaOH溶液调节pH=11.5,得到Zn的前驱体溶液;将Zn的前驱体转入三口瓶中,在氮气保护下迅速注入NaHSe溶液,油浴100℃回流,磁力搅拌1h后取出放入冰箱中快速冷却至室温,得到无色透明溶液,即为制备好的ZnSe QDs溶液。取制备好的ZnSe量子点15 mL,其中ZnSe量子点的浓度为2.7×10-3 mol/L,加入0.0138 g Zn(Ac)2、0.0277 g还原性谷胱甘肽和0.01 g硫脲,用配置好的浓度为1 mol/L NaOH溶液调节pH值为10.5,在磁力搅拌下,油浴100℃回流,磁力搅拌反应2 h后放入冰箱快速冷却至室温,得到淡黄色水溶性高发光效率的ZnSe/ZnS量子点。 3.1 Preparation of ZnSe/ZnS quantum dot solution. First, ZnSe quantum dots were prepared by chemical co-precipitation method. Under the protection of nitrogen, 0.01g NaBH 4 and 0.0061g Se powder were dissolved in 2 mL distilled water, heated to 40°C, and NaHSe solution was obtained after complete dissolution; 0.0439 g Zn( Ac) 2 was dissolved in 20 mL of distilled water, and after it was completely dissolved, 0.0737 g of reduced glutathione was added, and the pH was adjusted to 11.5 with 1mol/L NaOH solution to obtain a Zn precursor solution; Into a three-necked flask, quickly inject NaHSe solution under nitrogen protection, reflux in an oil bath at 100°C, magnetically stir for 1 hour, take it out and put it in a refrigerator to cool rapidly to room temperature to obtain a colorless and transparent solution, which is the prepared ZnSe QDs solution. Take 15 mL of prepared ZnSe quantum dots, in which the concentration of ZnSe quantum dots is 2.7×10 -3 mol/L, add 0.0138 g Zn(Ac) 2 , 0.0277 g reduced glutathione and 0.01 g thiourea, and use The prepared NaOH solution with a concentration of 1 mol/L adjusts the pH value to 10.5. Under magnetic stirring, the oil bath is refluxed at 100°C. After 2 hours of magnetic stirring reaction, put it in the refrigerator and quickly cool it to room temperature to obtain light yellow water-soluble high luminous efficiency ZnSe/ZnS quantum dots.
3.2磁性纳米颗粒的制备。采用专利公开号为CN101597495A的方法制备Fe3O4/CoO核壳结构磁性纳米颗粒。 3.2 Preparation of magnetic nanoparticles. The Fe 3 O 4 /CoO core-shell magnetic nanoparticles are prepared by adopting the method with the patent publication number of CN101597495A.
3.3采用共混包埋法制备羧甲基壳聚糖磁性纳米复合物。称取0.35 g Fe3O4/CoO磁性纳米颗粒溶于30 mL pH =7.4,浓度为0.01mol/L的PBS缓冲溶液中,通氮气去氧,利用超声波清洗机将磁性粒子分散均匀,得到分散均匀的Fe3O4/CoO纳米颗粒溶液;称取0.65 g羧甲基壳聚糖溶于20 mL pH =7.4的PBS缓冲溶液中,同时加入0.3 g 1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDAC)活化羧甲基壳聚糖表面的基团;之后将羧甲基壳聚糖溶液加入Fe3O4/CoO纳米颗粒溶液,在恒温水浴振荡器中25℃振荡5 h,反应结束后用磁铁收集产物,再依次用蒸馏水和PBS( pH=7.4)缓冲溶液充分洗涤,即得到羧甲基壳聚糖磁性纳米复合物。 3.3 Preparation of carboxymethyl chitosan magnetic nanocomposites by blending embedding method. Weigh 0.35 g of Fe 3 O 4 /CoO magnetic nanoparticles and dissolve them in 30 mL of PBS buffer solution with a pH of 7.4 and a concentration of 0.01mol/L, pass nitrogen gas to remove oxygen, and use an ultrasonic cleaner to disperse the magnetic particles evenly to obtain a dispersed Homogeneous Fe 3 O 4 /CoO nanoparticle solution; weigh 0.65 g carboxymethyl chitosan and dissolve it in 20 mL of PBS buffer solution with pH = 7.4, and add 0.3 g 1-ethyl-(3-dimethyl Aminopropyl) carbodiimide hydrochloride (EDAC) activates the groups on the surface of carboxymethyl chitosan; then add the carboxymethyl chitosan solution to the Fe 3 O 4 /CoO nanoparticle solution and shake in a constant temperature water bath Shake in a container at 25°C for 5 h. After the reaction, the product was collected with a magnet, and then thoroughly washed with distilled water and PBS (pH=7.4) buffer solution to obtain carboxymethyl chitosan magnetic nanocomposites.
3.4采用离子交联法制备磁性荧光复合纳米颗粒。取3.1制备的浓缩的水相ZnSe/ZnS量子点,异丙醇分离提纯后溶于5mL蒸馏水中,并加入焦磷酸钠和纤维素硫酸钠,其中焦磷酸钠和纤维素硫酸钠的浓度分别为2 mg/mL和4 mg/mL,ZnSe/ZnS量子点浓度为0.1 mol/L,得到反应溶液A;取0.035 g步骤3.3中制备的羧甲基壳聚糖修饰的磁性纳米复合物溶于10 mL蒸馏水中,超声30 min,使磁性纳米微粒分散均匀,并加入质量浓度为2 mg/mL 聚二烯丙基二甲基氯化铵,得到反应溶液B;将A溶液逐滴加入B溶液中,在25℃的恒温水浴振荡器中振荡6h,磁铁收集反应产物,用蒸馏水清洗反应产物,即得磁性荧光双功能纳米材料。图3为制备的磁性荧光复合纳米颗粒的TEM照片。 3.4 Preparation of magnetic fluorescent composite nanoparticles by ionic cross-linking method. Take the concentrated aqueous phase ZnSe/ZnS quantum dots prepared in 3.1, separate and purify them with isopropanol, dissolve them in 5 mL of distilled water, and add sodium pyrophosphate and sodium cellulose sulfate, wherein the concentrations of sodium pyrophosphate and sodium cellulose sulfate are respectively 2 mg/mL and 4 mg/mL, the concentration of ZnSe/ZnS quantum dots was 0.1 mol/L, and the reaction solution A was obtained; 0.035 g of the carboxymethyl chitosan-modified magnetic nanocomposite prepared in step 3.3 was dissolved in 10 Sonicate in mL distilled water for 30 min to disperse the magnetic nanoparticles evenly, and add polydiallyldimethylammonium chloride with a mass concentration of 2 mg/mL to obtain reaction solution B; add solution A to solution B dropwise , shake in a constant temperature water bath oscillator at 25°C for 6h, collect the reaction product with a magnet, wash the reaction product with distilled water, and obtain the magnetic fluorescent bifunctional nanomaterial. Fig. 3 is a TEM photo of the prepared magnetic fluorescent composite nanoparticles.
实施例4: Example 4:
4.1 采用水相法制备CdSe量子点. 在氮气保护下,将0.0106 g NaBH4与0.0063 g Se粉溶于2 mL蒸馏水中,加热至40℃,完全溶解后得到NaHSe溶液;取0.0533 g Cd(Ac)2溶入20 mL蒸馏水中,待其完全溶解后加入1.0 mmol 巯基丙酸,用1mol/L的NaOH溶液调节pH=11.5,得到Cd的前驱体溶液;将Cd的前驱体转入三口瓶中,在氮气保护下迅速注入NaHSe溶液,油浴100℃回流,磁力搅拌1h后取出放入冰箱中快速冷却至室温,得到无色透明溶液,即为制备好的CdSe QDs溶液。 4.1 Prepare CdSe quantum dots by the aqueous phase method. Under the protection of nitrogen, dissolve 0.0106 g NaBH 4 and 0.0063 g Se powder in 2 mL distilled water, heat to 40 °C, and obtain NaHSe solution after complete dissolution; take 0.0533 g Cd(Ac ) 2 was dissolved in 20 mL of distilled water, and after it was completely dissolved, 1.0 mmol of mercaptopropionic acid was added, and the pH was adjusted to 11.5 with 1 mol/L NaOH solution to obtain a Cd precursor solution; transfer the Cd precursor into a three-necked flask , quickly inject NaHSe solution under the protection of nitrogen, reflux the oil bath at 100 ° C, magnetically stir for 1 hour, take it out and put it in the refrigerator to cool to room temperature quickly to obtain a colorless and transparent solution, which is the prepared CdSe QDs solution.
4.2 磁性纳米颗粒的制备。采用专利公开号为CN 101928043 A的方法制备α-Fe2O3磁性纳米颗粒。 4.2 Preparation of magnetic nanoparticles. The method of patent publication number CN 101928043 A is used to prepare α-Fe 2 O 3 magnetic nanoparticles.
4.3采用共混包埋法制备羧甲基壳聚糖磁性纳米复合物(CMCH-MNPs)。称取0.5 g α-Fe2O3磁性纳米颗粒溶于30 mL pH =7.4,浓度为0.01mol/L的PBS缓冲溶液中,通氮气去氧,利用超声波清洗机将磁性粒子分散均匀,得到分散均匀的α-Fe2O3纳米颗粒溶液;称取0.8 g羧甲基壳聚糖溶于20 mL pH =7.4的PBS缓冲溶液中,同时加入0.5 g 1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDAC)活化羧甲基壳聚糖表面的基团;之后将羧甲基壳聚糖溶液加入α-Fe2O3纳米颗粒溶液,在恒温水浴振荡器中25℃振荡6 h,反应结束后用磁铁收集产物,再依次用蒸馏水和PBS( pH=7.4)缓冲溶液充分洗涤,即得到羧甲基壳聚糖磁性纳米复合物。 4.3 Carboxymethyl chitosan magnetic nanocomposites (CMCH-MNPs) were prepared by blending embedding method. Weigh 0.5 g of α-Fe 2 O 3 magnetic nanoparticles and dissolve them in 30 mL of PBS buffer solution with a pH of 7.4 and a concentration of 0.01mol/L, pass nitrogen gas to remove oxygen, and use an ultrasonic cleaner to disperse the magnetic particles evenly to obtain a dispersed Uniform α-Fe 2 O 3 nanoparticle solution; weigh 0.8 g carboxymethyl chitosan and dissolve it in 20 mL of PBS buffer solution with pH = 7.4, and add 0.5 g 1-ethyl-(3-dimethyl Aminopropyl) carbodiimide hydrochloride (EDAC) activates the groups on the surface of carboxymethyl chitosan; then add the carboxymethyl chitosan solution to the α-Fe 2 O 3 nanoparticle solution and shake in a constant temperature water bath Shake in a container at 25°C for 6 h. After the reaction, the product was collected with a magnet, and then thoroughly washed with distilled water and PBS (pH=7.4) buffer solution to obtain carboxymethyl chitosan magnetic nanocomposites.
4.4采用离子交联法制备磁性荧光复合纳米颗粒。取4.1制备的浓缩的水相CdSe量子点,异丙醇分离提纯后溶于5 mL蒸馏水中,并加入钼酸钠和羧酸纤维素,其中钼酸钠和羧酸纤维素的浓度分别为2.5 mg/mL和6 mg/mL,CdSe量子点浓度为0.25 mol/L,得到反应溶液A;取0.05 g步骤4.3中制备的羧甲基壳聚糖修饰的磁性纳米复合物溶于10 mL蒸馏水中,超声30 min,使磁性纳米微粒分散均匀,并加入质量浓度为5 mg/mL 聚二烯丙基二甲基氯化铵,得到反应溶液B;将A溶液逐滴加入B溶液中,在25℃的恒温水浴振荡器中振荡10 h,磁铁收集反应产物,用蒸馏水清洗反应产物,即得磁性荧光双功能纳米材料。图4为制备的磁性荧光复合纳米颗粒的磁滞回线。 4.4 Preparation of magnetic fluorescent composite nanoparticles by ionic cross-linking method. Take the concentrated aqueous CdSe quantum dots prepared in 4.1, separate and purify them with isopropanol, dissolve them in 5 mL of distilled water, and add sodium molybdate and cellulose carboxylate, where the concentrations of sodium molybdate and cellulose carboxylate are 2.5 mg/mL and 6 mg/mL, and the concentration of CdSe quantum dots was 0.25 mol/L to obtain reaction solution A; take 0.05 g of the carboxymethyl chitosan-modified magnetic nanocomposite prepared in step 4.3 and dissolve it in 10 mL of distilled water , sonicate for 30 min to disperse the magnetic nanoparticles evenly, and add polydiallyldimethylammonium chloride with a mass concentration of 5 mg/mL to obtain reaction solution B; add solution A dropwise to solution B, ℃ in a constant temperature water bath oscillator for 10 h, the reaction product was collected by a magnet, and the reaction product was washed with distilled water to obtain a magnetic fluorescent bifunctional nanomaterial. Figure 4 is the hysteresis loop of the prepared magnetic fluorescent composite nanoparticles.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510124944.4A CN104844839B (en) | 2015-03-23 | 2015-03-23 | A kind of preparation method of magnetic fluorescence composite nanometer particle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510124944.4A CN104844839B (en) | 2015-03-23 | 2015-03-23 | A kind of preparation method of magnetic fluorescence composite nanometer particle |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104844839A true CN104844839A (en) | 2015-08-19 |
CN104844839B CN104844839B (en) | 2017-03-15 |
Family
ID=53844859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510124944.4A Expired - Fee Related CN104844839B (en) | 2015-03-23 | 2015-03-23 | A kind of preparation method of magnetic fluorescence composite nanometer particle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104844839B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105400517A (en) * | 2015-10-30 | 2016-03-16 | 玉林师范学院 | Method for preparing dual-functional magnetic fluorescent probe for detecting cadmium ions and application thereof |
CN106467294A (en) * | 2016-10-17 | 2017-03-01 | 浙江和谱生物科技有限公司 | The aqueous phase preparation method of suppression tumor cell nanometer cadmium telluride |
CN107858144A (en) * | 2017-11-10 | 2018-03-30 | 四川大学 | A kind of magnetic material for efficient detection circulating tumor cell and preparation method thereof |
CN111423878A (en) * | 2020-04-30 | 2020-07-17 | 山东交通学院 | Fluorescent magnetic composite nanoparticle, preparation method thereof, and biological probe prepared from the fluorescent magnetic composite nanoparticle |
CN114507299A (en) * | 2022-03-21 | 2022-05-17 | 昆明理工大学 | Method for extracting hemicellulose by adopting ammonium group modified neodymium iron boron magnetic particles |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524925A (en) * | 2003-09-18 | 2004-09-01 | 吉林大学 | Fluorescent magnetic nanocomposite and its preparation method and application |
US20070110813A1 (en) * | 2005-11-02 | 2007-05-17 | Aeris Therapeutics, Inc. | Polycation-polyanion complexes, compositions and methods of use thereof |
CN103041400A (en) * | 2012-09-20 | 2013-04-17 | 杭州师范大学 | Preparation method of antimicrobial peptide loaded chitosan/gamma polyglutamic acid composite nanoparticles |
-
2015
- 2015-03-23 CN CN201510124944.4A patent/CN104844839B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524925A (en) * | 2003-09-18 | 2004-09-01 | 吉林大学 | Fluorescent magnetic nanocomposite and its preparation method and application |
US20070110813A1 (en) * | 2005-11-02 | 2007-05-17 | Aeris Therapeutics, Inc. | Polycation-polyanion complexes, compositions and methods of use thereof |
CN103041400A (en) * | 2012-09-20 | 2013-04-17 | 杭州师范大学 | Preparation method of antimicrobial peptide loaded chitosan/gamma polyglutamic acid composite nanoparticles |
Non-Patent Citations (1)
Title |
---|
丁永玲: "磁性荧光复合纳米粒子的制备与性能表征", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105400517A (en) * | 2015-10-30 | 2016-03-16 | 玉林师范学院 | Method for preparing dual-functional magnetic fluorescent probe for detecting cadmium ions and application thereof |
CN105400517B (en) * | 2015-10-30 | 2018-03-13 | 玉林师范学院 | Detect difunctional magnetic fluorescence probe preparation method and its application of cadmium ion |
CN106467294A (en) * | 2016-10-17 | 2017-03-01 | 浙江和谱生物科技有限公司 | The aqueous phase preparation method of suppression tumor cell nanometer cadmium telluride |
CN106467294B (en) * | 2016-10-17 | 2018-08-24 | 浙江和谱生物科技有限公司 | Inhibit the aqueous phase preparation method of tumour cell nanometer cadmium telluride |
CN107858144A (en) * | 2017-11-10 | 2018-03-30 | 四川大学 | A kind of magnetic material for efficient detection circulating tumor cell and preparation method thereof |
CN107858144B (en) * | 2017-11-10 | 2019-10-11 | 四川大学 | A magnetic material for efficient detection of circulating tumor cells and its preparation method |
CN111423878A (en) * | 2020-04-30 | 2020-07-17 | 山东交通学院 | Fluorescent magnetic composite nanoparticle, preparation method thereof, and biological probe prepared from the fluorescent magnetic composite nanoparticle |
CN111423878B (en) * | 2020-04-30 | 2022-11-08 | 山东交通学院 | Fluorescent magnetic composite nano-particles, preparation method thereof and biological probe prepared from fluorescent magnetic composite nano-particles |
CN114507299A (en) * | 2022-03-21 | 2022-05-17 | 昆明理工大学 | Method for extracting hemicellulose by adopting ammonium group modified neodymium iron boron magnetic particles |
CN114507299B (en) * | 2022-03-21 | 2023-02-03 | 昆明理工大学 | Method for extracting hemicellulose by adopting ammonium group modified neodymium iron boron magnetic particles |
Also Published As
Publication number | Publication date |
---|---|
CN104844839B (en) | 2017-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chiozzi et al. | Inorganic–organic core/shell nanoparticles: progress and applications | |
Ling et al. | Synthesis, surface modification, and applications of magnetic iron oxide nanoparticles | |
Nosrati et al. | PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells | |
Thota et al. | Metal nanoparticles: synthesis and applications in pharmaceutical sciences | |
CN104840977B (en) | A kind of preparation method of magnetic fluorescence composite Nano pharmaceutical carrier | |
Siddiqi et al. | Biogenic fabrication of iron/iron oxide nanoparticles and their application | |
CN104745192B (en) | A kind of magnetic fluorescent dual-function nanoparticle probe and preparation method thereof | |
Babic et al. | Poly (L-lysine)-modified iron oxide nanoparticles for stem cell labeling | |
Bhattacharya et al. | Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging | |
Sounderya et al. | Use of core/shell structured nanoparticles for biomedical applications | |
CN103525414B (en) | Carbon quantum dot magnetic fluorescent dual-function nano material and preparation method thereof | |
CN102861921B (en) | A kind of preparation method of core-shell magnetic/gold nanocomposite particles | |
CN102327625B (en) | Preparation method of water-soluble nano composite material | |
CN103525405B (en) | Magnetic fluorescent difunctional nano material based on natural polymer and preparation method thereof | |
Fattahi Nafchi et al. | In vitro study: synthesis and evaluation of Fe3O4/CQD magnetic/fluorescent nanocomposites for targeted drug delivery, MRI, and cancer cell labeling applications | |
Ganguly et al. | Layer by layer controlled synthesis at room temperature of tri‐modal (MRI, fluorescence and CT) core/shell superparamagnetic IO/human serum albumin nanoparticles for diagnostic applications | |
CN104844839B (en) | A kind of preparation method of magnetic fluorescence composite nanometer particle | |
CN102051177A (en) | Water-soluble fluorescent magnetic nano particles and preparation method thereof | |
Wang et al. | Multifunctional Fe 3 O 4–CdTe@ SiO 2–carboxymethyl chitosan drug nanocarriers: synergistic effect towards magnetic targeted drug delivery and cell imaging | |
CN105462580B (en) | A kind of zinc doping ferroferric oxide nano granules of fluorescence targeting and preparation | |
CN102660255A (en) | Magnetic fluorescent nanoparticle with biological activity and method for preparing magnetic fluorescent nanoparticle | |
Abu-Huwaij et al. | Perceptive review on properties of iron oxide nanoparticles and their antimicrobial and anticancer activity | |
Wang et al. | β-Ga2O3: Cr3+ nanoparticle: A new platform with near infrared photoluminescence for drug targeting delivery and bio-imaging simultaneously | |
CN104762085A (en) | Magnetic fluorescent composite nanometer biological probe and preparation method thereof | |
Uthappa et al. | Nanotechnology advances for the development of various drug carriers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170315 Termination date: 20210323 |